Income Statement
ERNEXA THERAPEUTICS INC.
ERNA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | 0.60 | 0.07 | - | - | 5.80 | 19.81 | 23.34 | 21.27 | 22.31 | 24.52 | 26.05 | 23.75 | 24.06 | 23.87 |
|
Cost of Revenue
|
0.00 | 0.10 | 0.24 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | 0.49 | -0.17 | - | - | 5.80 | 19.81 | 23.34 | 21.27 | 22.31 | 24.52 | 26.05 | 23.75 | 24.06 | 23.87 |
|
Operating Expenses
|
9.32 | 16.16 | 20.97 | 33.22 | 113.55 | 12.11 | 21.57 | 23.13 | 22.68 | 24.59 | 31.41 | 30.79 | 24.87 | 25.13 | 27.15 |
|
Research & Development
|
4.16 | 4.60 | 5.92 | 10.39 | 12.71 | - | - | - | - | - | - | - | - | - | - |
|
Selling, General & Administrative
|
5.16 | 13.13 | 14.59 | 16.84 | 14.72 | 8.09 | 13.18 | 14.49 | 15.59 | 16.46 | 18.06 | 18.37 | 16.45 | 18.25 | 20.45 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-9.32 | -15.67 | -21.14 | -33.22 | -113.55 | -6.31 | -1.76 | 0.20 | -1.40 | -2.28 | -6.90 | -4.74 | -1.12 | -1.06 | -3.28 |
|
Non-Operating Income
|
-4.81 | -28.84 | -0.54 | 8.68 | -8.75 | -1.89 | 0.26 | 0.53 | 0.39 | -0.61 | -0.32 | -0.20 | 0.11 | 0.02 | 0.02 |
|
Interest Income
|
0.10 | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 |
|
Interest Expense
|
- | 3.93 | 0.61 | - | - | 0.12 | 0.24 | 0.30 | 0.43 | 0.52 | 0.28 | 0.22 | 0.03 | 0.04 | 0.05 |
|
Other Non-Op Income / Expense
|
0.22 | 0.07 | -0.33 | -1.17 | 0.90 | 1.89 | -0.26 | -0.53 | 0.89 | - | - | - | - | -0.02 | - |
|
Income Before Tax
|
-14.13 | -44.51 | -21.67 | -24.53 | -122.30 | -4.42 | -2.02 | -0.32 | -1.01 | -2.89 | -7.21 | -4.95 | -1.01 | -1.08 | - |
|
Income Tax Expense
|
-0.05 | 0.03 | 0.00 | 0.05 | -122.30 | -0.01 | 0.03 | -0.06 | 0.07 | 0.04 | 0.01 | 0.08 | 0.05 | -0.08 | 0.16 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-14.08 | -44.54 | -21.67 | -24.58 | 0.00 | 4.42 | 2.05 | 0.26 | 1.08 | 2.92 | -7.23 | -5.03 | -1.05 | -1.00 | -3.42 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-9.25 | -15.54 | -21.05 | -33.06 | -113.44 | -6.11 | -1.40 | 0.52 | -1.07 | -1.86 | -6.41 | -4.14 | -0.39 | -0.34 | -2.39 |
|
Earnings Per Share (Basic)
|
-2.24 | -3.26 | -4.08 | -8.06 | -2.82 | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-2.24 | -3.26 | -4.08 | -8.06 | -2.82 | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
6.31 | 13.65 | 5.31 | 3.05 | 43.31 | - | - | - | - | - | - | - | - | 0.07 | 60.40 |
|
Diluted Weighted Avg Shares
|
6.31 | 13.65 | 5.31 | 3.05 | 43.31 | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | -4.44 | -1.98 | -0.40 | -0.96 | -2.87 | -7.53 | - | -1.19 | -0.95 | -3.48 |